20 May 2013
Keywords: celltech, cdp870, works, well, ph, ii, crohn
Article | 11 March 2002
Celltech of the UK's anti-tumor necrosis factor-alfa antibody, CDP870,has been shown to be an effective treatment for Crohn's disease ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 March 2002
17 May 2013
© 2013 thepharmaletter.com